Kumaraguru Raja
Stock Analyst at Brookline Capital Markets
(0.22)
# 4,664
Out of 5,104 analysts
191
Total ratings
31.2%
Success rate
-6%
Average return
Main Sectors:
Stocks Rated by Kumaraguru Raja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMEA Biomea Fusion | Initiated Coverage: Buy | $10 | $0.6119 | +1,534.25% | 1 | Oct 7, 2026 | |
| EDSA Edesa Biotech | Initiated Coverage: Buy | $18 → $21 | $2.17 | +867.74% | 10 | Jun 29, 2026 | |
| ERNA Ernexa Therapeutics | Initiated Coverage: Buy | $30 | $1.99 | +1,407.54% | 1 | May 7, 2026 | |
| IRD Opus Genetics | Initiated Coverage: Buy | $10 → $8 | $4.27 | +87.35% | 4 | Dec 1, 2025 | |
| MDCX Medicus Pharma | Reiterated: Buy | $12 → $20 | $1.88 | n/a | 2 | Sep 24, 2025 | |
| NBP NovaBridge Biosciences | Reiterated: Buy | $6 → $8 | $1.01 | n/a | 2 | Aug 28, 2025 | |
| INTS Intensity Therapeutics | Upgraded: Buy | $75 | $3.50 | n/a | 2 | Aug 12, 2025 | |
| HURA TuHURA Biosciences | Initiated Coverage: Buy | $9 | $1.72 | n/a | 1 | Jun 23, 2025 | |
| MNPR Monopar Therapeutics | Reiterated: Buy | $3 → $58 | $72.81 | n/a | 7 | May 13, 2025 | |
| PALI Palisade Bio | Initiated Coverage: Buy | $38 | $1.25 | n/a | 1 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $1.15 | n/a | 1 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $3.75 | n/a | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $3.18 | n/a | 1 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $6.18 | n/a | 1 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 → $5 | $0.6619 | n/a | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $74 | $0.000001 | n/a | 5 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $330 | $0.000001 | n/a | 3 | Oct 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.84 | n/a | 9 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.4621 | n/a | 9 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $2.20 | n/a | 20 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 | $10.87 | n/a | 15 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $7 | $0.40 | n/a | 8 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.9131 | n/a | 6 | Aug 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $2.56 | n/a | 6 | Jun 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.06 | n/a | 5 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $0.8951 | n/a | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14.00 | $0.44 | n/a | 5 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $0.907 | n/a | 8 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $2 | $0.8548 | n/a | 2 | Sep 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.14 | n/a | 3 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $6 | $0.135 | n/a | 5 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $4.34 | n/a | 1 | Feb 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $0.0006 | n/a | 9 | Dec 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.23 | n/a | 3 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.35 | n/a | 2 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8745 | n/a | 3 | Dec 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $3.57 | n/a | 4 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.11 | n/a | 1 | Aug 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.82 | n/a | 2 | Aug 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.24 | n/a | 1 | May 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.26 | n/a | 2 | May 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $1.95 | n/a | 1 | May 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.2986 | n/a | 1 | May 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.5 → $0.4 | $9.14 | n/a | 2 | Jun 29, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $537 → $480 | $930.67 | n/a | 4 | Feb 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $174.48 | n/a | 1 | Apr 6, 2015 |
Biomea Fusion
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $0.6119
Upside: +1,534.25%
Edesa Biotech
Jun 29, 2026
Initiated Coverage: Buy
Price Target: $18 → $21
Current: $2.17
Upside: +867.74%
Ernexa Therapeutics
May 7, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $1.99
Upside: +1,407.54%
Opus Genetics
Dec 1, 2025
Initiated Coverage: Buy
Price Target: $10 → $8
Current: $4.27
Upside: +87.35%
Medicus Pharma
Sep 24, 2025
Reiterated: Buy
Price Target: $12 → $20
Current: $1.88
Upside: n/a
NovaBridge Biosciences
Aug 28, 2025
Reiterated: Buy
Price Target: $6 → $8
Current: $1.01
Upside: n/a
Intensity Therapeutics
Aug 12, 2025
Upgraded: Buy
Price Target: $75
Current: $3.50
Upside: n/a
TuHURA Biosciences
Jun 23, 2025
Initiated Coverage: Buy
Price Target: $9
Current: $1.72
Upside: n/a
Monopar Therapeutics
May 13, 2025
Reiterated: Buy
Price Target: $3 → $58
Current: $72.81
Upside: n/a
Palisade Bio
Nov 20, 2024
Initiated Coverage: Buy
Price Target: $38
Current: $1.25
Upside: n/a
Aug 22, 2024
Initiated Coverage: Buy
Price Target: $9
Current: $1.15
Upside: n/a
Jul 9, 2024
Initiated Coverage: Buy
Price Target: $80
Current: $3.75
Upside: n/a
Jun 6, 2024
Initiated Coverage: Buy
Price Target: $8
Current: $3.18
Upside: n/a
Mar 3, 2023
Initiated Coverage: Buy
Price Target: $9
Current: $6.18
Upside: n/a
Jan 5, 2023
Initiated Coverage: Buy
Price Target: $6 → $5
Current: $0.6619
Upside: n/a
Nov 29, 2022
Reiterated: Buy
Price Target: $80 → $74
Current: $0.000001
Upside: n/a
Oct 17, 2022
Reiterated: Buy
Price Target: $12 → $330
Current: $0.000001
Upside: n/a
Aug 15, 2022
Reiterated: Buy
Price Target: n/a
Current: $3.84
Upside: n/a
Aug 11, 2022
Reiterated: Buy
Price Target: $6
Current: $0.4621
Upside: n/a
Aug 11, 2022
Reiterated: Buy
Price Target: $31
Current: $2.20
Upside: n/a
Aug 10, 2022
Reiterated: Buy
Price Target: $74
Current: $10.87
Upside: n/a
Aug 8, 2022
Rated: Buy
Price Target: $10 → $7
Current: $0.40
Upside: n/a
Aug 1, 2022
Reiterated: Buy
Price Target: n/a
Current: $0.9131
Upside: n/a
Jun 2, 2022
Reiterated: Buy
Price Target: $12
Current: $2.56
Upside: n/a
May 24, 2022
Reiterated: Buy
Price Target: n/a
Current: $1.06
Upside: n/a
May 13, 2022
Reiterated: Buy
Price Target: $22
Current: $0.8951
Upside: n/a
May 2, 2022
Reiterated: Buy
Price Target: $14.00
Current: $0.44
Upside: n/a
Apr 5, 2022
Reiterated: Buy
Price Target: $45
Current: $0.907
Upside: n/a
Sep 28, 2021
Reiterated: Buy
Price Target: $14 → $2
Current: $0.8548
Upside: n/a
Aug 17, 2021
Reiterated: Buy
Price Target: $7
Current: $3.14
Upside: n/a
Mar 23, 2021
Reiterated: Buy
Price Target: $12 → $6
Current: $0.135
Upside: n/a
Feb 2, 2021
Initiated Coverage: Buy
Price Target: $10
Current: $4.34
Upside: n/a
Dec 16, 2020
Reiterated: Buy
Price Target: $35
Current: $0.0006
Upside: n/a
Feb 20, 2020
Reiterated: Buy
Price Target: $6
Current: $1.23
Upside: n/a
Mar 28, 2019
Rated: Hold
Price Target: n/a
Current: $2.35
Upside: n/a
Dec 24, 2018
Rated: Hold
Price Target: n/a
Current: $0.8745
Upside: n/a
Oct 22, 2018
Reiterated: Buy
Price Target: $25
Current: $3.57
Upside: n/a
Aug 30, 2018
Reiterated: Hold
Price Target: n/a
Current: $5.11
Upside: n/a
Aug 4, 2017
Reiterated: Buy
Price Target: n/a
Current: $1.82
Upside: n/a
May 26, 2017
Reiterated: Buy
Price Target: n/a
Current: $8.24
Upside: n/a
May 22, 2017
Reiterated: Buy
Price Target: n/a
Current: $1.26
Upside: n/a
May 16, 2017
Reiterated: Hold
Price Target: $10
Current: $1.95
Upside: n/a
May 10, 2017
Reiterated: Buy
Price Target: n/a
Current: $0.2986
Upside: n/a
Jun 29, 2016
Downgraded: Hold
Price Target: $3.5 → $0.4
Current: $9.14
Upside: n/a
Feb 25, 2016
Initiated Coverage: Buy
Price Target: $537 → $480
Current: $930.67
Upside: n/a
Apr 6, 2015
Reiterated: Buy
Price Target: $120
Current: $174.48
Upside: n/a